5-years of endovenous laser ablation (EVLA) for the treatment of varicose veins--a prospective study

Int J Surg. 2009 Aug;7(4):347-9. doi: 10.1016/j.ijsu.2009.05.001. Epub 2009 May 14.


Purpose: This prospective study evaluates the results of Endovenous laser ablation (EVLA) for the treatment of varicose veins.

Methods: Data were prospectively collected for all patients undergoing EVLA for varicose veins in our unit including clinical outcomes (CEAP classification) and post-operative duplex.

Results: 624 EVLA procedures were performed from April 2004 to February 2009. There were 527 LSV EVLA cases, 449 of which were for the above-knee segment only. There were 94 SSV EVLA cases and 3 patients needed LSV EVLA on the same leg at the same time. 84% were done under general anesthetic including 126 patients who underwent bilateral procedures at the same session. There were no intra-operative complications, and a 1% incidence of thrombophlebitis, and <1% incidence of neuropraxia. During a median follow-up of 20 months (Range 2-51) there was no clinical or duplex evidence of recurrence and no recannalisation of the treated vein.

Conclusions: Our 5-year experience suggests that EVLA is a safe and effective alternative to conventional surgery for the treatment of varicose veins. Bilateral procedures were well tolerated by patients even under local anaesthesia.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anesthesia, Local
  • Female
  • Follow-Up Studies
  • Humans
  • Laser Therapy / adverse effects
  • Laser Therapy / methods*
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures / methods
  • Patient Satisfaction
  • Postoperative Complications / physiopathology
  • Prospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome
  • Ultrasonography
  • Varicose Veins / diagnostic imaging
  • Varicose Veins / physiopathology
  • Varicose Veins / surgery*
  • Young Adult